Pulmonx

Pulmonx

Minimally-invasive medical devices and technologies for the diagnosis and treatment of pulmonary disorders.

Launch date
Employees
Market cap
CAD444m
Enterprise valuation
CAD364m (Public information from Sep 2024)
Redwood City California (HQ)
Authorizing premium user...